InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
17
T+90 hit rate
0%
T+90 mean return
-26.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Krognes Steve E., Chief Financial Officer. Insider active across 2 companies, notably Denali Therapeutics Inc.. In total, 49 disclosures have been recorded. Split: 0 buy · 17 sells. Total volume traded: €3.9m. Activity tracked since 19 August 2021. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations49 total
6,408 shares0Common StockSEC:0001666236-26-000015:0
154 shares0Common StockSEC:0001666236-26-000011:0
6,037 shares0Common StockSEC:0001714899-25-000139:0
154 shares0Common StockSEC:0001576280-25-000155:0
155 shares0Common StockSEC:0001576280-25-000138:0
154 shares0Common StockSEC:0001576280-25-000108:0
154 shares0Common StockSEC:0001576280-25-000048:0
154 shares0Common StockSEC:0001576280-25-000032:0
3,339 shares@ US$20.811.6% of flowCommon StockSEC:0001714899-25-000048:0
30,000 shares@ US$20.2513.9% of flowCommon StockSEC:0001714899-25-000002:0
155 shares0Common StockSEC:0001576280-25-000002:0
154 shares0Common StockSEC:0001576280-24-000289:0
154 shares0Common StockSEC:0001576280-24-000253:0
30,000 shares@ US$29.0318.7% of flowCommon StockSEC:0001714899-24-000200:0
154 shares0Common StockSEC:0001576280-24-000228:0
155 shares0Common StockSEC:0001576280-24-000196:0
1,727 shares@ US$23.790.9% of flowCommon StockSEC:0001714899-24-000196:0
154 shares0Common StockSEC:0001576280-24-000184:0
688 shares@ US$21.790.3% of flowCommon StockSEC:0001714899-24-000156:0
154 shares0Common StockSEC:0001576280-24-000160:0
5,592 shares0Common StockSEC:0001576280-24-000138:0
5,967 shares0Common StockSEC:0001714899-24-000142:0
155 shares0Common StockSEC:0001576280-24-000122:0
154 shares0Common StockSEC:0001576280-24-000096:0
92,500 shares@ US$20.5042.1% of flowCommon StockSEC:0001714899-24-000098:0
25 of 49 declarations
About Krognes Steve E.
Steve E. Krognes is the Chief Financial Officer and Treasurer of Denali Therapeutics Inc. He is responsible for the company's financial management, including financial planning, risk management, and investor relations. With a strong background in the industry, he plays a key role in the strategic direction of the company and maximizing shareholder value.
